Cargando…
Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma
Through a three-step study that relies on biomarker discovery, training, and validation, we identified a set of five exosomal microRNAs (miRNAs) that can be used to evaluate the risk of gallbladder carcinoma (GBC), including miR-552-3p, miR-581, miR-4433a-3p, miR-496, and miR-203b-3p. When validated...
Autores principales: | Yang, Pinghua, Song, Fengliang, Yang, Xinwei, Yan, Xingzhou, Huang, Xinyu, Qiu, Zhengjun, Wen, Zhijian, Liang, Chi, Xin, Xianglei, Lei, Zhengqin, Zhang, Kecheng, Yang, Jue, Liu, Hu, Wang, Hongcheng, Xiang, Shijun, Li, Liang, Zhang, Baohua, Wang, Hongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420508/ https://www.ncbi.nlm.nih.gov/pubmed/36043050 http://dx.doi.org/10.1016/j.isci.2022.104816 |
Ejemplares similares
-
MiR-552-3p promotes malignant progression of gallbladder carcinoma by reactivating the Akt/β-catenin signaling pathway due to inhibition of the tumor suppressor gene RGMA
por: Song, Fengliang, et al.
Publicado: (2021) -
An RNA–RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity
por: Wei, Yanping, et al.
Publicado: (2021) -
GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma
por: Chen, Junyi, et al.
Publicado: (2015) -
N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes
por: Wei, Yanping, et al.
Publicado: (2023) -
The clinical outcomes of extended resections in patients with IV stage gallbladder cancers: A retrospective study from a large tertiary center
por: Zhang, Kecheng, et al.
Publicado: (2022)